I3 Verticals (IIIV) has disclosed a new risk, in the Regulation category.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
I3 Verticals faces significant business risks due to potential violations of complex healthcare laws and regulations related to its former Healthcare RCM Business. These regulations cover critical areas such as billing, fraud prevention, and data security, and any breaches could lead to severe penalties and reputational damage. Despite efforts to comply, the company remains vulnerable to enforcement actions and indemnification obligations under the Healthcare RCM Purchase Agreement with Infinx. Such challenges, even if ultimately unsuccessful, could be costly and harm I3 Verticals’ ability to retain and attract customers.
The average IIIV stock price target is $35.25, implying 47.24% upside potential.
To learn more about I3 Verticals’ risk factors, click here.